MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04482cam a2200325 i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250918150606.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120216s2011 nyua 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780071767286 |
| Terms of availability |
RM58.60 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0071767282 |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
|---|
| Level of rules in bibliographic description |
201204091528 |
| Level of effort used to assign nonsubject heading access points |
ruzini |
| Level of effort used to assign subject headings |
201203061523 |
| Level of effort used to assign classification |
zainol |
| Level of effort used to assign subject headings |
201202161352 |
| Level of effort used to assign classification |
yusri |
| Level of effort used to assign subject headings |
201202161351 |
| Level of effort used to assign classification |
yusri |
| y |
02-16-2012 |
| z |
yusri |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UKM |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QV4.S918b 2011 9 |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QV4 |
| Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) |
.S918b 2011 9 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Stringer, Janet L. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Basic concepts in pharmacology : |
| Remainder of title |
what you need to know for each drug class / |
| Statement of responsibility, etc. |
Janet L. Stringer |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Fourth edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
New York : |
| Name of publisher, distributor, etc. |
McGraw-Hill Medical, |
| Date of publication, distribution, etc. |
[2011] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 240 pages : |
| Other physical details |
ill ; |
| Dimensions |
24 cm. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
</b> Sex Steroids; <b>Chapter 38.</b> Thyroid and Parathyroid Drugs<b>Chapter 39.</b> Insulin, Glucagon and Oral Hypoglycemic Drugs; <b>Part VII: Miscellaneous Drugs</b>; <b>Chapter 40.</b> Histamine and Antihistamines; <b>Chapter 41.</b> Respiratory Drugs; <b>Chapter 42.</b> Drugs that Affect the GI Tract; <b>Chapter 43.</b> Nonnarcotic Analgesics and Anti-Inflammatory Drugs; <b>Chapter 44.</b> Immunosuppressives; <b>Chapter 45.</b> Drugs Used in Osteoporosis; <b>Chapter 46.</b> Toxicology and poisoning |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Machine generated contents note: <b>Chapter 1.</b> Where to Start; <b>Part I: General Principles</b>; <b>Chapter 2.</b> Receptor Theory; <b>Chapter 3.</b> Absorption, Distribution and Clearance; <b>Chapter 4.</b> Pharmacokinetics; <b>Chapter 5.</b> Drug Metabolism and Renal Elimination; <b>Part II: Drugs That Affect the Autonomic Nervous System</b>; <b>Chapter 6.</b> Review of the Autonomic Nervous System; <b>Chapter 7.</b> Cholinergic Agonists; <b>Chapter 8.</b> Cholinergic Antagonists; <b>Chapter 9.</b> Adrenergic Agonists; <b>Chapter 10.</b> Adrenergic Antagonists; <b>Part III: Drugs That Affect the Cardiovascular System</b>; <b>Chapter 11.</b> Antihypertensive Drugs; <b>Chapter 12.</b> Drugs used ischemic heart disease and congestive heart failure <b>Chapter 13.</b> Antiarrrhytmic Drugs; <b>Chapter 14.</b> Drugs that Affect Blood; <b>Chapter 15.</b> Lipid-Lowering Drugs; <b>Part IV: Drugs Acting on the Central Nervous System</b>; <b>Chapter 16.</b> Drugs used in dementia 17.</b>Anxiolytic and Hypnotic Drugs; <b>Chapter 18.</b> Drugs Used in Mood Disorders; <b>Chapter 19.</b> Antipsychotics or Neuroleptics; <b>Chapter 20.</b> Drugs Used in Parkinson's Disease; <b>Chapter 21.</b> Antiepileptic Drugs; <b>Chapter 22 </b> Narcotics (opiates); <b>Chapter 23.</b> General Anesthetics; <b>Chapter 24.</b> Local Anesthetics; Part V: Chemotherapeutic agents<b>;<b>Chapter 25.</b> Introduction to Chemotherapy; <b>Chapter 26.</b> Inhibitors of Cell Wall Synthesis; <b>Chapter 27.</b> Proteins Synthesis Inhibitors; <b>Chapter 28.</b> Folate Anatgonists; <b>Chapter 29.</b> Quinolones and Urinary Tract Antiseptics; <b>Chapter 30.</b> Drugs Used in Tuberculosis and Leprosy; <b>Chapter 31.</b> Antifungal Drugs; <b>Chapter 32.</b> Anthelmintic Drugs; <b>Chapter 33.</b> Antiviral Drugs; <b>Chapter 34.</b> Antiprotozoal Drugs; <b>Chapter 35.</b> Anticancer Drugs; <b>Part VI: Drugs that Affect the Endocrine System</b>; <b>Chapter 36.</b> Andrenocortical Hormones; <b>Chapter 37 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
'A proven method for learning the most difficult-to-understand concepts in pharmacology. Great for USMLE review! Basic in Pharmacology provides students with a complete framework for studying the fundamental principles of drug actions. This unique study system helps students set priorities, minimize memorization, and reduce stress.The book includes study techniques not found in any other book and details exactly what student need to know about each drug class to pass the course and the USMLE. Features: Simplifies the learning process by presenting drugs by class. Reinforces essential concepts and definitions. Written in a conversational engaging style. Organizes and condenses must-know drug information. NEW larger trim size. Numerous summary tables, illustrations, and boxes encapsulate key concepts. The content you need to understand essential pharmacology material:'--Provided by publisher |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacological Phenomena |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical preparations |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
|---|
| a |
.b15243862 |
| b |
2021-05-28 |
| c |
2019-11-12 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
AM |
| Suppress in OPAC |
No |
| Call number prefix |
QV4.S918b 2011 9 |
| 914 ## - VTLS Number |
|---|
| VTLS Number |
vtls003487969 |
| 991 ## - LOCAL NOTE (NAMA FAKULTI/INSTITUT/PUSAT) |
|---|
| a |
Fakulti Farmasi, KKL |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| Library |
PERPUSTAKAAN DR ABDUL LATIFF |
| Operator's initials, OID (RLIN) |
2012-03-02 |
| Cataloger's initials, CIN (RLIN) |
m |
| Material Type (Sierra) |
Printed Books |
| Language |
English |
| Country |
|
| -- |
0 |
| -- |
.b15243862 |
